NCT02366975View on ClinicalTrials.gov

TRT on BPH Hypoganadal MetS Patients. Florence-PROTEST

PHASE4CompletedINTERVENTIONAL
Enrollment

143

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

January 31, 2017

Study Completion Date

February 28, 2017

Conditions
Prostatic HyperplasiaLower Urinary Tract SymptomsHypogonadism
Interventions
DRUG

Testosterone gel 2%

testosterone gel 2% (50mg/die).

OTHER

Placebo

placebo gel

Trial Locations (2)

Unknown

Ambulatori Medicina della Sessualità e Andrologia, Florence

Clinica Urologica - Azienda Ospedaliero-Universitaria Careggi, Florence

All Listed Sponsors
lead

University of Florence

OTHER

NCT02366975 - TRT on BPH Hypoganadal MetS Patients. Florence-PROTEST | Biotech Hunter | Biotech Hunter